Multivessel Coronary Artery Disease

Immediate PCI of nonculprit lesions during index hospitalization for STEMI was shown to be noninferior with fewer adverse events vs. a staged strategy addressing the nonculprit lesions after successful primary PCI, a speaker reported.

Complete revascularization was associated with reduced HF hospitalization and both CV and all-cause death among patients presenting with ACS and multivessel CAD, researchers reported in the Journal of the American Heart Association.

BOSTON — Addition of fractional flow reserve to the classic SYNTAX score enabled researchers to identify patients with multivessel CAD undergoing PCI who would have similar 1-year outcomes as those who received CABG, a speaker reported.

BOSTON — At a median follow-up of 11.8 years, most outcomes did not differ between PCI with an everolimus-eluting stent and CABG in patients with multivessel CAD, according to new data from the BEST trial.

WASHINGTON — Complete revascularization, as opposed to culprit lesion-only revascularization, was associated with better angina-related quality of life in patients with STEMI and multivessel CAD, a speaker reported.

WASHINGTON — In patients with three-vessel CAD, those who underwent fractional flow reserve-guided PCI had similar quality of life at 1 year compared with those who underwent CABG, according to new data from the FAME 3 trial.

Among patients with acute MI, cardiogenic shock and multivessel CAD, multivessel PCI was associated with elevated risk for in-hospital complications and mortality compared with culprit-lesion-only PCI, researchers reported.

An analysis of the team approach to decision-making for multivessel CAD indicated that the consensus of a heart team was discordant with patients’ original treating interventionalist in nearly one-third of cases, researchers reported.